Yingzi Xu

USPTO Granted Patents = 7 (Patent Applications = 8)

EPO Patents = 1 (Patent Applications = 11)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

Terns Pharmaceuticals, Inc.

patents

Years Active: 2020-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454524 - (r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias (2025-10-28),

2. 12398127 - Thyroid hormone receptor beta agonist compounds (2025-08-26),

3. 12240835 - Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity (2025-03-04),

4. 11203587 - Thyroid hormone receptor beta agonist compounds (2021-12-21),

5. 10919911 - Tricyclic ASK1 inhibitors (2021-02-16),

6. 10889571 - Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias (2021-01-12),

7. 10800767 - Thyroid hormone receptor beta agonist compounds (2020-10-13),

Title: Top Inventor in Palo Alto

Introduction: Bartley K. Andre is a prominent inventor based in Palo Alto, California. He has made significant contributions to various fields through his innovative ideas and patents.

Latest Patents: Bartley K. Andre holds several patents that showcase his expertise and creativity in technology and engineering.

Career Highlights: Throughout his career, Bartley has achieved numerous milestones, establishing himself as a leader in his field.

Collaborations: He has worked with various organizations and individuals, fostering partnerships that enhance his innovative projects.

Conclusion: Bartley K. Andre continues to be a driving force in innovation, inspiring future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.